Sharechat Logo

Analysts question handling of Bendon bid by directors

By Nick Stride

Friday 15th February 2002

Text too small?
Eyebrows are being raised over Bendon directors' handling of competing takeover bids from the company's own management and Pacific Retail Group.

Analysts were yesterday questioning the independent directors' release, even before PRG published the terms of its bid, of the valuation of Bendon contained in an independent appraisal report.

Appraiser Grant Samuel values the company's shares at 194c to 219c, higher than both PRG's 190c cash bid and the effective 181c offered by a consortium of AMP and Hugo Venter, Bendon's managing director.

Also causing some puzzlement was the independent directors' assertion they had commissioned the Grant Samuel report "on the merits of PRG's proposed offer."

The report was in fact commissioned before PRG announced its interest in bidding for Bendon, but after the Venter/AMP bid was announced.

PRG yesterday explained the rationale for its bid.

It said opportunities for significant growth in its core appliance retailing area were limited.

Bendon was a marketer, wholesaler and retailer with different, but complementary characteristics to PRG's business.

"This initiative to diversify Pacific Retail's core business strengths, and to look to add value through operating expertise and synergies, represents a very attractive opportunity," a Stock Exchange release said.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report